{
    "id": 28874,
    "fullName": "EGFR C797G",
    "impact": "missense",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "EGFR C797G lies within the ATP-binding pocket in the protein kinase domain of the Egfr protein (PMID: 25964297). C797G has been demonstrated to confer resistance to third-generation EGFR inhibitors (PMID: 25964297, PMID: 29807405), and results in reduced palmitoylation, loss of constitutive activation and loss of ability to form dimers upon ligand stimulation compared to wild-type EGFR as demonstrated by reduced phosphorylation of Egfr in culture (PMID: 26378037).",
            "references": [
                {
                    "id": 14939,
                    "pubMedId": 26378037,
                    "title": "Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26378037"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 3620,
                    "pubMedId": 25964297,
                    "title": "The Allelic Context of the C797S Mutation Acquired upon Treatment with Third-Generation EGFR Inhibitors Impacts Sensitivity to Subsequent Treatment Strategies.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25964297"
                },
                {
                    "id": 12676,
                    "pubMedId": 29807405,
                    "title": "Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29807405"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "C797G",
    "createDate": "10/25/2018",
    "updateDate": "05/02/2019",
    "referenceTranscriptCoordinates": {
        "id": 177572,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55181398T>G",
        "cDna": "c.2389T>G",
        "protein": "p.C797G",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15134,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, a patient with non-small cell lung cancer initially responded to Tagrisso (osimertinib), and EGFR C797G, C797S, L858R, L781Q, T790M, and TFG-ALK were identified in post-progression tumor samples (PMID: 29883838).",
            "molecularProfile": {
                "id": 30781,
                "profileName": "TFG - ALK EGFR L718Q EGFR T790M EGFR C797G EGFR C797S EGFR L858R"
            },
            "therapy": {
                "id": 660,
                "therapyName": "Osimertinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 12672,
                    "pubMedId": 29883838,
                    "title": "Receptor Tyrosine Kinase Fusions and BRAF Kinase Fusions are Rare but Actionable Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29883838"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20733,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a retrospective analysis, EGFR C797S in cis with EGFR T790M were identified in 3 of 100 patients with non-small cell lung cancer at treatment discontinuation of Tagrisso (osimertinib) (PMID: 31839416).",
            "molecularProfile": {
                "id": 35317,
                "profileName": "EGFR T790M EGFR C797G"
            },
            "therapy": {
                "id": 660,
                "therapyName": "Osimertinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 18023,
                    "pubMedId": 31839416,
                    "title": "Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31839416"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30780,
            "profileName": "EGFR C797G",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 30781,
            "profileName": "TFG - ALK EGFR L718Q EGFR T790M EGFR C797G EGFR C797S EGFR L858R",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 35317,
            "profileName": "EGFR T790M EGFR C797G",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 177572,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55181398T>G",
            "cDna": "c.2389T>G",
            "protein": "p.C797G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}